Westpac Banking Corp Becton Dickinson & CO Transaction History

Westpac Banking Corp

$1.49 Trillion
Q3 2024

A detailed history of Westpac Banking Corp transactions in Becton Dickinson & CO stock. As of the latest transaction made, Westpac Banking Corp holds 3,898 shares of BDX stock, worth $925,307. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,898

Previous 3,669 6.24%

Holding current value

$925,307

Previous $857 Million 9.6%

% of portfolio

0.06%

Previous 0.07%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$221.47 - $242.41 $50,716 - $55,511	229 Added 6.24%	3,898 $940 Million
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $576,629 - $630,687	2,562 Added 231.44%	3,669 $857 Million
Q2 2024 Aug 12, 2024	SELL	$225.07 - $246.17 $380,143 - $415,781	-1,689 Reduced 60.41%	1,107 $857 Million
Q1 2024 May 09, 2024	BUY	$233.45 - $247.73 $4,902 - $5,202	21 Added 0.76%	2,796 $692 Million
Q4 2023 Feb 08, 2024	BUY	$232.24 - $267.23 $70,833 - $81,505	305 Added 12.35%	2,775 $677 Million
Q3 2023 Nov 09, 2023	BUY	$254.9 - $283.59 $65,764 - $73,166	258 Added 11.66%	2,470 $639 Million
Q2 2023 Aug 10, 2023	SELL	$238.39 - $265.32 $5.82 Million - $6.47 Million	-24,399 Reduced 91.69%	2,212 $584 Million
Q4 2022 Feb 06, 2023	BUY	$218.29 - $256.91 $174,632 - $205,528	800 Added 3.1%	26,611 $6.77 Billion
Q3 2022 Nov 08, 2022	SELL	$51.03 - $264.23 $903,588 - $4.68 Million	-17,707 Reduced 40.69%	25,811 $5.75 Billion
Q2 2022 Aug 10, 2022	SELL	$234.74 - $275.42 $1.73 Million - $2.04 Million	-7,389 Reduced 14.51%	43,518 $10.7 Billion
Q1 2022 May 11, 2022	SELL	$243.64 - $270.48 $180,293 - $200,155	-740 Reduced 1.43%	50,907 $13.2 Million
Q4 2021 Feb 08, 2022	SELL	$230.08 - $250.94 $9.45 Million - $10.3 Million	-41,061 Reduced 44.29%	51,647 $13 Billion
Q3 2021 Oct 27, 2021	BUY	$232.72 - $256.47 $6.24 Million - $6.88 Million	26,824 Added 40.71%	92,708 $22.2 Million
Q2 2021 Aug 11, 2021	BUY	$232.65 - $254.58 $230,556 - $252,288	991 Added 1.53%	65,884 $15.6 Million
Q1 2021 May 13, 2021	BUY	$232.09 - $256.88 $263,190 - $291,301	1,134 Added 1.78%	64,893 $15.4 Million
Q4 2020 Feb 11, 2021	SELL	$221.92 - $245.94 $3.04 Million - $3.37 Million	-13,697 Reduced 17.68%	63,759 $15.6 Million
Q3 2020 Nov 10, 2020	BUY	$215.77 - $276.76 $7.08 Million - $9.08 Million	32,802 Added 73.46%	77,456 $17.6 Million
Q2 2020 Aug 12, 2020	SELL	$219.9 - $263.41 $4.33 Million - $5.19 Million	-19,694 Reduced 30.61%	44,654 $10.4 Million
Q1 2020 May 14, 2020	BUY	$195.69 - $279.01 $483,745 - $689,712	2,472 Added 4.0%	64,348 $14.4 Million
Q4 2019 Feb 11, 2020	BUY	$236.45 - $266.82 $3.53 Million - $3.99 Million	14,946 Added 31.85%	61,876 $16.4 Million
Q3 2019 Nov 13, 2019	SELL	$230.58 - $256.08 $23.4 Million - $26 Million	-101,395 Reduced 68.36%	46,930 $11.6 Million
Q2 2019 Aug 01, 2019	BUY	$217.4 - $246.08 $275,228 - $311,537	1,266 Added 0.86%	148,325 $0
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $2.84 Million - $3.41 Million	13,760 Added 10.32%	147,059 $0
Q4 2018 Feb 07, 2019	SELL	$204.73 - $257.93 $6.03 Million - $7.59 Million	-29,441 Reduced 18.09%	133,299 $29.3 Million
Q3 2018 Nov 13, 2018	SELL	$233.07 - $256.0 $3.03 Million - $3.33 Million	-13,000 Reduced 7.4%	162,740 $0
Q2 2018 Jul 18, 2018	BUY	$208.1 - $233.85 $5.59 Million - $6.28 Million	26,853 Added 18.04%	175,740 $0
Q1 2018 May 01, 2018	BUY	$205.46 - $240.27 $7.86 Million - $9.19 Million	38,268 Added 34.59%	148,887 $0
Q4 2017 Jan 18, 2018	BUY	$189.0 - $222.64 $4.04 Million - $4.76 Million	21,369 Added 23.94%	110,619 $0
Q3 2017 Oct 30, 2017	BUY	$186.89 - $198.9 $16.7 Million - $17.8 Million	89,250	89,250 $0

Others Institutions Holding BDX

# of Institutions

1,736

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $67.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Account

Westpac Banking Corp Becton Dickinson & CO Transaction History